OncoImmunology
Volume 11, 2022 - Issue 1
Open access
1,603
Views
1
CrossRef citations to date
0
Altmetric
Brief Report
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
Alfonso Serrano Del Vallea Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, Spain
https://orcid.org/0000-0001-9343-1050View further author information
Manuel Beltrán-Visiedoa Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, Spain
https://orcid.org/0000-0002-7977-8020View further author information
Victoria de Poo-Rodríguezb Hematology Service, Hospital Clínico Universitario Lozano Blesa, 50009Zaragoza, Spain;c HCU-Lozano Blesa-Hematology Research Group, IIS Aragón, 50009Zaragoza, Spain
https://orcid.org/0000-0002-0955-9949View further author information
Nelia Jiménez-Alduána Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, SpainView further author information
, Gemma Azacetab Hematology Service, Hospital Clínico Universitario Lozano Blesa, 50009Zaragoza, Spain;c HCU-Lozano Blesa-Hematology Research Group, IIS Aragón, 50009Zaragoza, Spain
https://orcid.org/0000-0001-5068-7355View further author information
Rosana Díeza Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, Spain;d Hematology Service, Hospital Universitario Miguel Servet, 50009Zaragoza, SpainView further author information
, Beatriz Martínez-Lázarob Hematology Service, Hospital Clínico Universitario Lozano Blesa, 50009Zaragoza, Spain;c HCU-Lozano Blesa-Hematology Research Group, IIS Aragón, 50009Zaragoza, SpainView further author information
, Isabel Izquierdoa Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, Spain;d Hematology Service, Hospital Universitario Miguel Servet, 50009Zaragoza, SpainView further author information
, Luis Palomerab Hematology Service, Hospital Clínico Universitario Lozano Blesa, 50009Zaragoza, Spain;c HCU-Lozano Blesa-Hematology Research Group, IIS Aragón, 50009Zaragoza, Spain
https://orcid.org/0000-0001-8515-3599View further author information
Javier Navala Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, Spain
https://orcid.org/0000-0003-2156-8378View further author information
Alberto Anela Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, SpainView further author information
& Isabel Marzoa Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009Zaragoza, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-2315-9079View further author information
Article: 2141973
|
Received 26 May 2022, Accepted 26 Oct 2022, Published online: 01 Nov 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.